Tolerability and safety of gastroretentive once-daily gabapentin tablets for the treatment of postherpetic neuralgia
Gordon A Irving,1 Michael Sweeney21Swedish Pain and Headache Center, Seattle, WA, USA; 2Depomed, Menlo Park, CA, USAObjective: An immediate-release formulation of gabapentin is approved for treatment of postherpetic neuralgia (PHN). This formulation, however, requires multiple daily dosing, usually...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2012-06-01
|
| Series: | Journal of Pain Research |
| Online Access: | http://www.dovepress.com/tolerability-and-safety-of-gastroretentive-once-daily-gabapentin-table-a10224 |